Stifel Financial Corp Invests $1.26 Million in Smith & Nephew plc (NYSE:SNN)

Stifel Financial Corp bought a new position in shares of Smith & Nephew plc (NYSE:SNN) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 40,399 shares of the medical equipment provider’s stock, valued at approximately $1,258,000.

Several other hedge funds have also recently bought and sold shares of SNN. Quantinno Capital Management LP raised its position in Smith & Nephew by 29.3% in the third quarter. Quantinno Capital Management LP now owns 53,226 shares of the medical equipment provider’s stock valued at $1,657,000 after purchasing an additional 12,057 shares during the period. Point72 DIFC Ltd purchased a new stake in shares of Smith & Nephew during the 3rd quarter valued at about $7,200,000. Atom Investors LP purchased a new stake in shares of Smith & Nephew during the 3rd quarter valued at about $400,000. Maverick Capital Ltd. acquired a new position in Smith & Nephew during the 3rd quarter worth approximately $2,086,000. Finally, Hantz Financial Services Inc. boosted its holdings in Smith & Nephew by 14.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 71,437 shares of the medical equipment provider’s stock worth $2,225,000 after acquiring an additional 8,917 shares during the period. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Price Performance

SNN stock opened at $24.66 on Monday. The stock’s 50 day moving average is $26.21 and its two-hundred day moving average is $27.89. Smith & Nephew plc has a 52-week low of $23.65 and a 52-week high of $31.72. The company has a market capitalization of $10.78 billion, a PE ratio of 12.58, a P/E/G ratio of 1.41 and a beta of 0.84. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SNN. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Berenberg Bank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Finally, StockNews.com cut shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.